BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
7/22/16 Amgen (AMGN) Romosozumab for Osteoporosis / Osteopenia Subscribers Only Subscribers Only Subscribers Only
7/22/16 Sumitomo Dainippon Pharma (4506:JP) SUN-101 for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
7/22/16 Valeant (VRX) Vesneo for Glaucoma / Ocular Hypertension (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
7/21/16 Allergan (AGN) Avycaz for Hospital Acquired (Nosocomial) Pneumonia (HAP) (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
7/21/16 Merck (MRK) Bezlotoxumab for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/22/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
07/24/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
07/24/16 Subscribers Only Subscribers Only Patent - Expiration
07/24/16 Subscribers Only Subscribers Only Patent - Expiration
07/24/16 Subscribers Only Subscribers Only Trial Data - Updated Results